相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fueling Innovation In Medical Devices (And Beyond): Venture Capital In Health Care
D. Clay Ackerly et al.
HEALTH AFFAIRS (2009)
Ethical and Scientific Implications of the Globalization of Clinical Research
Seth W. Glickman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer
Chaitanya R. Acharya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Economic implications of potential changes to regulatory and reimbursement policies for medical devices
Shelby D. Reed et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
The prognostic role of a gene signature from tumorigenic breast-cancer cells.
Rui Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Coverage options for promising technologies: Medicare's 'coverage with evidence development'
Sean R. Tunis et al.
HEALTH AFFAIRS (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
被撤回的出版物: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer (Retracted Article. See vol 356, pg 201, 2007)
Anil Potti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects
WE Evans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation
B Modan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)